ACT Form 4: CEO Granted RSUs and Dividend-Generated Awards
Rhea-AI Filing Summary
Enact Holdings, Inc. (ACT) reported insider awards for Rohit Gupta, President and CEO and director. On 09/08/2025 Mr. Gupta was issued three tranches of restricted stock units (RSUs) that will settle 1:1 into common shares: 171 RSUs, 201 RSUs and 245 RSUs. Each tranche reports a $0 price reflecting grant/reinvestment terms tied to a quarterly dividend of $0.21 per share paid on 09/08/2025.
The filing shows the reported beneficial ownership following these issuances as 31,593, 37,333 and 45,340 shares respectively for the three RSU lines. Vesting schedules are specified: the first tranche vests in three equal annual installments beginning 02/09/2024, the second beginning 02/16/2025 and the third beginning 02/21/2026. The Form 4 is signed by a power of attorney on 09/10/2025.
Positive
- RSU grants were issued to the CEO/director, reinforcing alignment of management incentives with shareholders
- Dividend reinvestment generated additional RSUs at a $0.21 dividend per share paid on 09/08/2025
- Clear vesting schedules disclosed for each RSU tranche, showing staged alignment over time
Negative
- None.
Insights
TL;DR: CEO/director received modest RSU grants and dividend-reinvestment RSUs, following standard vesting schedules.
The filing documents three separate RSU issuances to Rohit Gupta on 09/08/2025 totaling 617 RSUs vested across distinct schedules. Each RSU converts 1:1 into common stock and some additional RSUs resulted from a $0.21 quarterly dividend reinvestment. The report lists post-transaction beneficial ownership figures for each RSU line: 31,593, 37,333, and 45,340 shares respectively. This pattern is consistent with routine equity compensation and dividend reinvestment mechanics rather than an open-market purchase or sale.
TL;DR: Transactions reflect executive compensation administration, not a change in control or material outside action.
The Form 4 indicates the reporting person holds roles as both President and CEO and a director, and the reported activity consists of RSU issuances that vest over multi-year schedules. The inclusion of a power-of-attorney signature and explicit vesting commencement dates shows standard governance treatment of equity awards. There is no disclosure in this filing of option exercises, open-market trades, board changes, or other governance events.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 171 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 201 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 245 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 9, 2024 Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.21 per share, paid on September 8, 2025. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025 Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026